Oncology HandbookInteractive Reference

Handbooks

Staging, regimens, RT doses, key trials, biomarkers, and FRCR pearls — structured and searchable across 41 disease sites.

/

41 handbooks · 1,935 regimens · 12 systems

Showing 41 handbooks

Breast 1 sites

Breast Cancer Hormone receptor-positive, HER2, and triple-negative subtypes 72 regimens

Thoracic 3 sites

Pleural Mesothelioma Epithelioid, sarcomatoid, and biphasic pleural mesothelioma 21 regimens Lung Cancer (SCLC) Small cell lung cancer — staging, treatment, and management 36 regimens Thymic Cancer Thymoma and thymic carcinoma — surgery, RT, systemic therapy 21 regimens

GI — Upper 7 sites

Biliary Cancers Cholangiocarcinoma & gallbladder cancer regimens 43 regimens Gastric Cancer Gastric and gastro-oesophageal junction adenocarcinoma 53 regimens HCC Hepatocellular carcinoma — systemic and locoregional 24 regimens Oesophageal Cancer Oesophageal and OGJ cancer, all histologies 93 regimens Pancreatic Cancer Pancreatic adenocarcinoma — localised to metastatic 23 regimens Ampullary Ampullary and periampullary carcinoma 74 regimens Hepatobiliary Cancers Combined hepatocellular-cholangiocarcinoma and rare hepatobiliary tumours 0 regimens

GI — Lower 4 sites

Small Bowel Cancer Small bowel adenocarcinoma and lymphoma 66 regimens Anal Squamous cell carcinoma of the anal canal and margin 24 regimens Lower GI Cancers Colon and rectal cancer — adjuvant and metastatic 80 regimens Peritoneal Mesothelioma Epithelioid, sarcomatoid, and biphasic peritoneal mesothelioma 23 regimens

Genitourinary 5 sites

Bladder Cancer NMIBC, MIBC, and metastatic bladder cancer 31 regimens Prostate Cancer Localised, biochemical relapse, mHSPC, mCRPC 42 regimens Kidney Cancer Clear cell, papillary, chromophobe RCC and variant histologies 42 regimens Penile Cancer Squamous cell carcinoma of the penis — organ-preserving approaches 28 regimens Testicular Cancer Seminoma and non-seminomatous germ cell tumours 19 regimens

Gynaecologic 5 sites

Cervical Cancer Squamous cell carcinoma, adenocarcinoma, and adenosquamous 60 regimens Ovarian Cancer Epithelial ovarian, fallopian tube, and primary peritoneal cancer 117 regimens Uterine Cancer Endometrioid, serous, clear cell, and carcinosarcoma 23 regimens Vaginal Cancer Squamous cell carcinoma, adenocarcinoma, and melanoma of the vagina 38 regimens Vulvar Cancer Squamous cell carcinoma of the vulva and vulval intraepithelial neoplasia 28 regimens

Head & Neck 3 sites

Head and Neck HNSCC, nasopharyngeal, salivary, thyroid 81 regimens Occult Primary Cervical nodal metastases of unknown primary origin 38 regimens Thyroid Cancer Differentiated, medullary, and anaplastic thyroid carcinoma 41 regimens

Neuroendocrine 1 sites

Neuroendocrine Tumours NETs and NEC — gastroenteropancreatic and lung 77 regimens

Skin 5 sites

Skin Cancers Melanoma, BCC, cSCC — systemic treatment options 29 regimens Cutaneous Lymphoma Mycosis fungoides, Sezary syndrome, and primary cutaneous lymphomas 33 regimens Melanoma Cutaneous, uveal, and mucosal melanoma — all stages 56 regimens Kaposi Sarcoma HHV-8 associated, classic, endemic, and iatrogenic KS 28 regimens Merkel Cell Carcinoma Merkel cell polyomavirus-associated neuroendocrine skin cancer 30 regimens

Sarcoma & Bone 3 sites

GIST Gastrointestinal stromal tumour — KIT/PDGFRA driven 27 regimens Bone Cancer Osteosarcoma, Ewing sarcoma, chordoma, chondrosarcoma 47 regimens Sarcoma Soft tissue sarcoma, GIST, desmoid, and retroperitoneal sarcoma 117 regimens

CNS 2 sites

CNS Cancers Gliomas, glioblastoma, meningioma, medulloblastoma, and CNS lymphoma 89 regimens Neuroblastoma Low, intermediate, and high-risk neuroblastoma 14 regimens

Hematologic 2 sites

Hodgkin Lymphoma Classical HL and nodular lymphocyte-predominant HL 68 regimens Multiple Myeloma Smouldering and active myeloma, AL amyloidosis, and POEMS 79 regimens